Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-Deoxy-D-Glucose, also known as 6-Deoxyglucose or 6DG, is a monosaccharide that is structurally similar to glucose but lacks a hydroxyl group at the sixth carbon position. This modification makes it a useful tool in scientific research and various applications across different industries.

7658-08-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 7658-08-4 Structure
  • Basic information

    1. Product Name: 6-DEOXY-D-GLUCOSE
    2. Synonyms: EPIFUCOSE;D-QUINOVOSE;D-ISORHAMNOSE;DEOXY-D-GLUCOSE,6-;6-DEOXY-D-GLUCOSE;6-DEOXYGLUCOSE;QUINOVOSE;6-deoxy-D-glucose crystalline
    3. CAS NO:7658-08-4
    4. Molecular Formula: C6H12O5
    5. Molecular Weight: 164.16
    6. EINECS: 231-622-2
    7. Product Categories: N/A
    8. Mol File: 7658-08-4.mol
  • Chemical Properties

    1. Melting Point: 146°
    2. Boiling Point: 211.61°C (rough estimate)
    3. Flash Point: 209.3 °C
    4. Appearance: /
    5. Density: 1.1738 (rough estimate)
    6. Vapor Pressure: 1.99E-05mmHg at 25°C
    7. Refractive Index: 1.4230 (estimate)
    8. Storage Temp.: −20°C
    9. Solubility: H2O: 10 mg/mL, clear, colorless
    10. PKA: 12.50±0.20(Predicted)
    11. Merck: 13,8169
    12. CAS DataBase Reference: 6-DEOXY-D-GLUCOSE(CAS DataBase Reference)
    13. NIST Chemistry Reference: 6-DEOXY-D-GLUCOSE(7658-08-4)
    14. EPA Substance Registry System: 6-DEOXY-D-GLUCOSE(7658-08-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: 24/25
    4. WGK Germany: 3
    5. RTECS:
    6. F: 3-10
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 7658-08-4(Hazardous Substances Data)

7658-08-4 Usage

Uses

Used in Pharmaceutical Research:
6-Deoxy-D-Glucose is used as a research tool for studying the role of the carbon 6 hydroxyl group in the biological function of glucose. It helps in understanding the mechanisms of glucose metabolism and its impact on various physiological processes.
Used in Cancer Research:
In cancer research, 6-Deoxy-D-Glucose is used as a glucose analog to investigate the metabolism of cancer cells. Due to its structural similarity to glucose, it can be utilized to study the altered metabolic pathways in cancer cells and develop targeted therapies.
Used in Metabolic Studies:
6-Deoxy-D-Glucose is used as a metabolic probe in various metabolic studies. It can help researchers understand the role of glucose in energy production, glycolysis, and other metabolic pathways.
Used in Analytical Chemistry:
In analytical chemistry, 6-Deoxy-D-Glucose can be used as a reference compound for the development and validation of analytical methods for the detection and quantification of glucose and its analogs.
Used in Material Science:
6-Deoxy-D-Glucose can be used in material science for the synthesis of glucose-based polymers and materials with potential applications in drug delivery, tissue engineering, and other fields.
Used in Food Industry:
In the food industry, 6-Deoxy-D-Glucose can be used as a sweetener or a bulking agent in certain food products, providing an alternative to traditional sugars.
Used in Cosmetics Industry:
In the cosmetics industry, 6-Deoxy-D-Glucose can be used as an ingredient in various formulations, such as creams, lotions, and serums, due to its potential moisturizing and skin conditioning properties.

Purification Methods

6-Deoxy-D-glucose is purified by recrystallisation from EtOAc and is soluble in H2O, EtOH but insoluble in Et2O and Me2CO. [Srivastava & Lerner Carbohydr Res 64 263 1978; NMR: Angyal & Pickles Aust J Chem 25 1711 1972, Beilstein 1 IV 4260.]

Check Digit Verification of cas no

The CAS Registry Mumber 7658-08-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,6,5 and 8 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 7658-08:
(6*7)+(5*6)+(4*5)+(3*8)+(2*0)+(1*8)=124
124 % 10 = 4
So 7658-08-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3-,4+,5-,6+/m1/s1

7658-08-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name D-quinovose

1.2 Other means of identification

Product number -
Other names D-Glucose, 6-deoxy-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7658-08-4 SDS

7658-08-4Synthetic route

bayogenin {28-O-α-L-rhamnopyranosyl-(1->2)-[β-D-galactopyranosyl(1->3)]-[β-D-glucopyranosyl-(1->6)]-β-D-glucopyranosyl} ester

bayogenin {28-O-α-L-rhamnopyranosyl-(1->2)-[β-D-galactopyranosyl(1->3)]-[β-D-glucopyranosyl-(1->6)]-β-D-glucopyranosyl} ester

A

D-quionovose
7658-08-4

D-quionovose

B

D-glucose
50-99-7

D-glucose

C

D-Galactose
59-23-4

D-Galactose

Conditions
ConditionsYield
Stage #1: bayogenin {28-O-α-L-rhamnopyranosyl-(1->2)-[β-D-galactopyranosyl(1->3)]-[β-D-glucopyranosyl-(1->6)]-β-D-glucopyranosyl} ester With sulfuric acid In 1,4-dioxane for 1h; Reflux;
Stage #2: In 1,4-dioxane
A n/a
B n/a
C n/a
D 71.7%
Conditions
ConditionsYield
Stage #1: desacylperennisoside X With sulfuric acid In 1,4-dioxane for 1h; Reflux;
Stage #2: In 1,4-dioxane
A n/a
B n/a
C 65.8%
desacylperennisoside XI

desacylperennisoside XI

A

D-quionovose
7658-08-4

D-quionovose

B

D-glucose
50-99-7

D-glucose

C

D-Galactose
59-23-4

D-Galactose

Conditions
ConditionsYield
Stage #1: desacylperennisoside XI With sulfuric acid In 1,4-dioxane for 1h; Reflux;
Stage #2: In 1,4-dioxane
A n/a
B n/a
C n/a
D 61.4%
desacyl-perennisoside VIII

desacyl-perennisoside VIII

A

D-quionovose
7658-08-4

D-quionovose

B

D-Fucose
3615-37-0

D-Fucose

C

D-glucose
50-99-7

D-glucose

Conditions
ConditionsYield
Stage #1: desacyl-perennisoside VIII With sulfuric acid In 1,4-dioxane for 1h; Reflux;
Stage #2: In 1,4-dioxane
A n/a
B n/a
C n/a
D 52.2%
desacylperennisoside IX

desacylperennisoside IX

A

D-quionovose
7658-08-4

D-quionovose

B

D-Fucose
3615-37-0

D-Fucose

C

D-glucose
50-99-7

D-glucose

D

D-Galactose
59-23-4

D-Galactose

Conditions
ConditionsYield
Stage #1: desacylperennisoside IX With sulfuric acid In 1,4-dioxane for 1h; Reflux;
Stage #2: In 1,4-dioxane
A n/a
B n/a
C n/a
D n/a
E 50%
β-methyl-d-isorhamnoside

β-methyl-d-isorhamnoside

D-quionovose
7658-08-4

D-quionovose

Conditions
ConditionsYield
Hydrolysis;
methyl-<6-deoxy-α-D-glucopyranoside>

methyl-<6-deoxy-α-D-glucopyranoside>

D-quionovose
7658-08-4

D-quionovose

Conditions
ConditionsYield
With hydrogenchloride
O3,O5-benzylidene-O1,O2-isopropylidene-6-deoxy-α-D-glucofuranose

O3,O5-benzylidene-O1,O2-isopropylidene-6-deoxy-α-D-glucofuranose

D-quionovose
7658-08-4

D-quionovose

Conditions
ConditionsYield
With sulfuric acid
purginic acid

purginic acid

D-quionovose
7658-08-4

D-quionovose

Conditions
ConditionsYield
Hydrolysis;
Conditions
ConditionsYield
With water; trifluoroacetic acid at 100℃; for 0.5h;
3-O-[3-O-methyl-β-D-glucopyranosyl-(1->3)-β-D-glucopyranosyl-(1->4)-β-D-quinovopyranosyl-(1->2)-4-O-sodiumsulfato-β-D-xylopyranosyl]-22-oxo-9(11)-holostene-3β,12α,17α-triol
1033617-26-3

3-O-[3-O-methyl-β-D-glucopyranosyl-(1->3)-β-D-glucopyranosyl-(1->4)-β-D-quinovopyranosyl-(1->2)-4-O-sodiumsulfato-β-D-xylopyranosyl]-22-oxo-9(11)-holostene-3β,12α,17α-triol

A

D-xylose
58-86-6

D-xylose

B

D-quionovose
7658-08-4

D-quionovose

C

3-O-methyl-D-xylose
15075-11-3

3-O-methyl-D-xylose

D

D-glucose
50-99-7

D-glucose

E

C30H46O6

C30H46O6

Conditions
ConditionsYield
With water; trifluoroacetic acid at 120℃; for 2h;
3-O-[3-O-methyl-β-D-glucopyranosyl-(1->3)-β-D-glucopyranosyl-(1->4)-β-D-quinovopyranosyl-(1->2)-4-O-sodiumsulfato-β-D-xylopyranosyl]-22-oxo-9(11)-holostene-3β,12α,25-triol
1082071-34-8

3-O-[3-O-methyl-β-D-glucopyranosyl-(1->3)-β-D-glucopyranosyl-(1->4)-β-D-quinovopyranosyl-(1->2)-4-O-sodiumsulfato-β-D-xylopyranosyl]-22-oxo-9(11)-holostene-3β,12α,25-triol

A

D-xylose
58-86-6

D-xylose

B

D-quionovose
7658-08-4

D-quionovose

C

3-O-methyl-D-xylose
15075-11-3

3-O-methyl-D-xylose

D

D-glucose
50-99-7

D-glucose

E

C30H46O6

C30H46O6

Conditions
ConditionsYield
With water; trifluoroacetic acid at 120℃; for 2h;
fuscocineroside B
915213-96-6

fuscocineroside B

A

D-xylose
58-86-6

D-xylose

B

D-quionovose
7658-08-4

D-quionovose

C

3-O-methyl-D-xylose
15075-11-3

3-O-methyl-D-xylose

D

D-glucose
50-99-7

D-glucose

E

C30H46O5

C30H46O5

Conditions
ConditionsYield
With water; trifluoroacetic acid at 120℃; for 2h;
disodium (3β,9β,16β)-16-(acetyloxy)-18-oxo-18,20-epoxylanosta-7,24-dien-3-yl 3-O-methyl-β-D-glucopyranosyl-(1->3)-β-D-xylopyranosyl-(1->4)-6-deoxy-2-O-sulfonato-β-D-glucopyranosyl-(1->2)-4-O-sulfonato-β-D-xylopyranoside

disodium (3β,9β,16β)-16-(acetyloxy)-18-oxo-18,20-epoxylanosta-7,24-dien-3-yl 3-O-methyl-β-D-glucopyranosyl-(1->3)-β-D-xylopyranosyl-(1->4)-6-deoxy-2-O-sulfonato-β-D-glucopyranosyl-(1->2)-4-O-sulfonato-β-D-xylopyranoside

A

D-xylose
58-86-6

D-xylose

B

D-quionovose
7658-08-4

D-quionovose

Conditions
ConditionsYield
With water; trifluoroacetic acid at 120℃; for 2h;
disodium (3β,9β,16β)-16-(acetyloxy)-18-oxo-18,20-epoxylanosta-7,25-dien-3-yl 3-O-methyl-β-D-glucopyranosyl-(1->3)-β-D-xylopyranosyl-(1->4)-6-deoxy-2-O-sulfonato-β-D-glucopyranosyl-(1->2)-4-O-sulfonato-β-D-xylopyranoside

disodium (3β,9β,16β)-16-(acetyloxy)-18-oxo-18,20-epoxylanosta-7,25-dien-3-yl 3-O-methyl-β-D-glucopyranosyl-(1->3)-β-D-xylopyranosyl-(1->4)-6-deoxy-2-O-sulfonato-β-D-glucopyranosyl-(1->2)-4-O-sulfonato-β-D-xylopyranoside

A

D-xylose
58-86-6

D-xylose

B

D-quionovose
7658-08-4

D-quionovose

Conditions
ConditionsYield
With water; trifluoroacetic acid at 120℃; for 2h;
scammonic acid A

scammonic acid A

A

D-quionovose
7658-08-4

D-quionovose

B

L-Rhamnose
3615-41-6

L-Rhamnose

C

D-glucose
50-99-7

D-glucose

D

11-hydroxyhexadecanoic acid
502-75-0

11-hydroxyhexadecanoic acid

Conditions
ConditionsYield
With hydrogenchloride; water In ethanol for 1h; Reflux;
C26H22O12

C26H22O12

A

D-quionovose
7658-08-4

D-quionovose

(R)-2'-hydroxy-justirumalin

(R)-2'-hydroxy-justirumalin

Conditions
ConditionsYield
With β-D-glucosidase at 37℃; for 6h; pH=5; aq. acetate buffer; Enzymatic reaction;A 0.9 mg
B 1.2 mg
C48H58O29

C48H58O29

A

D-xylose
58-86-6

D-xylose

C

D-quionovose
7658-08-4

D-quionovose

D

L-Rhamnose
3615-41-6

L-Rhamnose

E

D-glucose
50-99-7

D-glucose

(R)-2'-hydroxy-justirumalin

(R)-2'-hydroxy-justirumalin

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane; water at 100℃; for 3h;
quamoclinic acid B methyl ester
1345337-77-0

quamoclinic acid B methyl ester

A

D-quionovose
7658-08-4

D-quionovose

B

C10H20O3
1310356-98-9

C10H20O3

Conditions
ConditionsYield
With hydrogenchloride; water at 95℃; for 1h;
(3S,11S)-ipurolic acid 11-O-β-D-quinovopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->3)-[O-β-D-quinovopyranosyl-(1->4)]-O-α-L-rhamnopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->2)-β-D-fucopyranoside
1287252-84-9

(3S,11S)-ipurolic acid 11-O-β-D-quinovopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->3)-[O-β-D-quinovopyranosyl-(1->4)]-O-α-L-rhamnopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->2)-β-D-fucopyranoside

A

D-quionovose
7658-08-4

D-quionovose

B

D-Fucose
3615-37-0

D-Fucose

C

L-Rhamnose
3615-41-6

L-Rhamnose

D

D-glucose
50-99-7

D-glucose

E

ipurolic acid

ipurolic acid

Conditions
ConditionsYield
With hydrogenchloride; water at 95℃; for 1h;
(3S,11S)-ipurolic acid 11-O-β-D-quinovopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->3)-[O-β-D-fucopyranosyl-(1->4)]-O-α-L-rhamnopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->2)-β-D-fucopyranoside
1310579-84-0

(3S,11S)-ipurolic acid 11-O-β-D-quinovopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->3)-[O-β-D-fucopyranosyl-(1->4)]-O-α-L-rhamnopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->2)-β-D-fucopyranoside

A

D-quionovose
7658-08-4

D-quionovose

B

D-Fucose
3615-37-0

D-Fucose

C

L-Rhamnose
3615-41-6

L-Rhamnose

D

D-glucose
50-99-7

D-glucose

E

ipurolic acid

ipurolic acid

Conditions
ConditionsYield
With hydrogenchloride; water at 95℃; for 1h;
(3S,11S)-ipurolic acid 11-O-β-D-fucoopyranosyl-(1->3)-O-β-D-quinovopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->3)-[O-β-D-fucopyranosyl-(1->4)]-O-α-L-rhamnopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->2)-β-D-fucopyranoside
1310579-86-2

(3S,11S)-ipurolic acid 11-O-β-D-fucoopyranosyl-(1->3)-O-β-D-quinovopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->3)-[O-β-D-fucopyranosyl-(1->4)]-O-α-L-rhamnopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->2)-β-D-fucopyranoside

A

D-quionovose
7658-08-4

D-quionovose

B

D-Fucose
3615-37-0

D-Fucose

C

L-Rhamnose
3615-41-6

L-Rhamnose

D

D-glucose
50-99-7

D-glucose

E

ipurolic acid

ipurolic acid

Conditions
ConditionsYield
With hydrogenchloride; water at 95℃; for 1h;
(3S,11S)-ipurolic acid 11-O-α-L-rhamnpyranosyl-(1->3)-O-β-D-quinovopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->3)-[O-β-D-quinovopyranosyl-(1->4)]-O-α-L-rhamnopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->2)-β-D-fucopyranoside
1287253-14-8

(3S,11S)-ipurolic acid 11-O-α-L-rhamnpyranosyl-(1->3)-O-β-D-quinovopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->3)-[O-β-D-quinovopyranosyl-(1->4)]-O-α-L-rhamnopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->2)-β-D-fucopyranoside

A

D-quionovose
7658-08-4

D-quionovose

B

D-Fucose
3615-37-0

D-Fucose

C

L-Rhamnose
3615-41-6

L-Rhamnose

D

D-glucose
50-99-7

D-glucose

E

ipurolic acid

ipurolic acid

Conditions
ConditionsYield
With hydrogenchloride; water at 95℃; for 1h;
squarroside VII
1331827-01-0

squarroside VII

A

D-quionovose
7658-08-4

D-quionovose

B

D-Fucose
3615-37-0

D-Fucose

C

D-glucose
50-99-7

D-glucose

Conditions
ConditionsYield
With hydrogenchloride; water In 1,4-dioxane at 100℃; for 1h;
aeginetic acid 5-O-β-D-quinovoside

aeginetic acid 5-O-β-D-quinovoside

A

D-quionovose
7658-08-4

D-quionovose

B

aeginetic acid
53537-92-1

aeginetic acid

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane; water for 1h; Reflux;
sodium β-D-glucopyranosyl 3-[(O-(4-O-sulfo-β-D-glucopyranosyl)-(1->3)-O-[α-L-rhamnopyranosyl-(1->2)]-α-L-arabinopyranosyl)oxy]-30-noroleana-12,20(29)-dien-28-oate

sodium β-D-glucopyranosyl 3-[(O-(4-O-sulfo-β-D-glucopyranosyl)-(1->3)-O-[α-L-rhamnopyranosyl-(1->2)]-α-L-arabinopyranosyl)oxy]-30-noroleana-12,20(29)-dien-28-oate

A

L-arabinose
5328-37-0

L-arabinose

B

D-quionovose
7658-08-4

D-quionovose

C

D-glucose
50-99-7

D-glucose

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane; water at 95℃; for 1h; Inert atmosphere;
O-β-D-glucopyranosyl-(1->6)-β-D-glucopyranosyl 3-[(O-β-D-glucopyranosyl-(1->3)-O-[α-L-rhamnopyranosyl-(1->2)]-α-L-arabinopyranosyl)oxy]-30-noroleana-12,20(29)-dien-28-oate
1260096-79-4

O-β-D-glucopyranosyl-(1->6)-β-D-glucopyranosyl 3-[(O-β-D-glucopyranosyl-(1->3)-O-[α-L-rhamnopyranosyl-(1->2)]-α-L-arabinopyranosyl)oxy]-30-noroleana-12,20(29)-dien-28-oate

A

L-arabinose
5328-37-0

L-arabinose

B

D-quionovose
7658-08-4

D-quionovose

C

D-glucose
50-99-7

D-glucose

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane; water at 95℃; for 1h; Inert atmosphere;
D-quionovose
7658-08-4

D-quionovose

1,2-diamino-1,4,5,6,7,8-hexahydro-4-(4-methoxyphenyl)-7,7-dimethyl-5-oxoquinoline-3-carbonitrile

1,2-diamino-1,4,5,6,7,8-hexahydro-4-(4-methoxyphenyl)-7,7-dimethyl-5-oxoquinoline-3-carbonitrile

1,5,6,7,8,9-hexahydro-2-((S,S,S,S)-1,2,3,4-tetrahydroxypentyl)-5-(4-methoxyphenyl)-8,8-dimethyl-6-oxo-[1,2,4]triazolo[1,5-a]quinoline-4-carbonitrile

1,5,6,7,8,9-hexahydro-2-((S,S,S,S)-1,2,3,4-tetrahydroxypentyl)-5-(4-methoxyphenyl)-8,8-dimethyl-6-oxo-[1,2,4]triazolo[1,5-a]quinoline-4-carbonitrile

Conditions
ConditionsYield
With iodine; acetic acid78%
D-quionovose
7658-08-4

D-quionovose

(3S)-O-(N-methoxyglycyl)betulinic acid
1101863-07-3

(3S)-O-(N-methoxyglycyl)betulinic acid

Conditions
ConditionsYield
In methanol; dichloromethane at 40℃; for 48h;8%
D-quionovose

D-quionovose

phenylhydrazine hydrochloride
59-88-1

phenylhydrazine hydrochloride

Conditions
ConditionsYield
With ethanol; water; sodium acetate phenyl-isorhodeosazone;
D-quionovose
7658-08-4

D-quionovose

6-deoxy-D-glucitol
71075-63-3

6-deoxy-D-glucitol

Conditions
ConditionsYield
With sodium amalgam; sulfuric acid; water
With sodium tetrahydroborate
D-quionovose
7658-08-4

D-quionovose

d-glucomethylonic acid
67337-08-0

d-glucomethylonic acid

Conditions
ConditionsYield
With potassium hydroxide; platinum on activated charcoal In water at 25℃; under 760 Torr; for 1.5h; Rate constant; Mechanism; relative, initial rate;
With bromine
Conditions
ConditionsYield
With nitric acid at 50 - 55℃;
D-quionovose
7658-08-4

D-quionovose

acetic anhydride
108-24-7

acetic anhydride

1,2,3,4-tetra-O-acetyl-6-deoxy-β-D-glucopyranose
17081-04-8

1,2,3,4-tetra-O-acetyl-6-deoxy-β-D-glucopyranose

Conditions
ConditionsYield
With sodium acetate
D-quionovose
7658-08-4

D-quionovose

acetone
67-64-1

acetone

6-deoxy-1,2-O-isopropylidene-α-D-glucofuranose
17668-66-5

6-deoxy-1,2-O-isopropylidene-α-D-glucofuranose

Conditions
ConditionsYield
With sulfuric acid
D-quionovose
7658-08-4

D-quionovose

(4-bromophenyl)hydrazine
589-21-9

(4-bromophenyl)hydrazine

lyxo-6-deoxy-[2]hexosulose-bis-(4-bromo-phenylhydrazone)

lyxo-6-deoxy-[2]hexosulose-bis-(4-bromo-phenylhydrazone)

Conditions
ConditionsYield
With acetic acid -bis-<4-bromo-phenylhydrazone>;
D-quionovose
7658-08-4

D-quionovose

(4-bromophenyl)hydrazine
589-21-9

(4-bromophenyl)hydrazine

D-arabino-6-deoxy-[2]hexosulose-bis-(4-bromo-phenylhydrazone); (4-bromo-phenyl)-d-isorhodeosazon

D-arabino-6-deoxy-[2]hexosulose-bis-(4-bromo-phenylhydrazone); (4-bromo-phenyl)-d-isorhodeosazon

Conditions
ConditionsYield
With acetic acid
D-quionovose

D-quionovose

2,2,2-trifluoro-N-methyl-N-(2,2,2-trifluoroacetyl)acetamide

2,2,2-trifluoro-N-methyl-N-(2,2,2-trifluoroacetyl)acetamide

N-benzyloxyamine
622-33-3

N-benzyloxyamine

A

trifluoroacetylated 6-deoxyglucose anti-O-benzyloxime
128613-57-0

trifluoroacetylated 6-deoxyglucose anti-O-benzyloxime

B

trifluoroacetylated 6-deoxyglucose syn-O-benzyloxime
128613-68-3

trifluoroacetylated 6-deoxyglucose syn-O-benzyloxime

Conditions
ConditionsYield
1.) NMP, 75 deg C, 30 min, 2.) NMP, RT, 5-10 min; Multistep reaction;
O-Methylhydroxylamin
67-62-9

O-Methylhydroxylamin

D-quionovose
7658-08-4

D-quionovose

1-(Trimethylsilyl)imidazole
18156-74-6

1-(Trimethylsilyl)imidazole

A

trimethylsilyl ether of 6-deoxyglucose anti-O-methyloxime
128705-55-5

trimethylsilyl ether of 6-deoxyglucose anti-O-methyloxime

B

trimethylsilyl ether of 6-deoxyglucose syn-O-methyloxime
128705-52-2

trimethylsilyl ether of 6-deoxyglucose syn-O-methyloxime

Conditions
ConditionsYield
1.) NMP, 75 deg C, 30 min, 2.) NMP, RT, 5-10 min; Multistep reaction;
D-quionovose
7658-08-4

D-quionovose

N-benzyloxyamine
622-33-3

N-benzyloxyamine

1-(Trimethylsilyl)imidazole
18156-74-6

1-(Trimethylsilyl)imidazole

A

trimethylsilyl ether of 6-deoxyglucose-O-benzyloxime
128613-99-0, 128614-00-6, 128614-01-7, 128614-03-9, 128614-04-0

trimethylsilyl ether of 6-deoxyglucose-O-benzyloxime

B

trimethylsilyl ether of 6-deoxygalactose-anti-O-benzyloxime
128614-01-7

trimethylsilyl ether of 6-deoxygalactose-anti-O-benzyloxime

Conditions
ConditionsYield
1.) NMP, 75 deg C, 30 min, 2.) NMP, RT, 5-10 min; Multistep reaction;
D-quionovose
7658-08-4

D-quionovose

ASPARAGINE
3130-87-8

ASPARAGINE

A

3,5,6-trimethyl-1,2-dihydropyrazin-2-one
57355-08-5

3,5,6-trimethyl-1,2-dihydropyrazin-2-one

B

3,6-dimethyl-5-ethyl-2(1H)-pyrazinone

3,6-dimethyl-5-ethyl-2(1H)-pyrazinone

C

3,5-dimethyl-6-ethyl-2(1H)-pyrazinone

3,5-dimethyl-6-ethyl-2(1H)-pyrazinone

D

3-methyl-5,6-diethyl-2(1H)-pyrazinone

3-methyl-5,6-diethyl-2(1H)-pyrazinone

Conditions
ConditionsYield
In water at 200℃; for 1h; Title compound not separated from byproducts;
In water at 200℃; for 1h;
Conditions
ConditionsYield
at 50 - 55℃;
D-quionovose
7658-08-4

D-quionovose

acetic anhydride
108-24-7

acetic anhydride

Acetic acid (1R,2R,3R)-2,3-diacetoxy-1-((S)-acetoxy-cyano-methyl)-butyl ester

Acetic acid (1R,2R,3R)-2,3-diacetoxy-1-((S)-acetoxy-cyano-methyl)-butyl ester

Conditions
ConditionsYield
Stage #1: D-quionovose With dmap; hydroxylamine at 60℃; for 0.5h;
Stage #2: acetic anhydride at 60℃; for 0.5h;
D-quionovose
7658-08-4

D-quionovose

O1,O2-isopropylidene-O5-(tetra-O-acetyl-β-D-glucopyranosyl)-6-deoxy-α-D-glucofuranose

O1,O2-isopropylidene-O5-(tetra-O-acetyl-β-D-glucopyranosyl)-6-deoxy-α-D-glucofuranose

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sulfuric acid
2: silver carbonate; chloroform
View Scheme
D-quionovose
7658-08-4

D-quionovose

O3-acetyl-O1,O2-isopropylidene-O5-(tetra-O-acetyl-β-D-glucopyranosyl)-6-deoxy-α-D-glucofuranose

O3-acetyl-O1,O2-isopropylidene-O5-(tetra-O-acetyl-β-D-glucopyranosyl)-6-deoxy-α-D-glucofuranose

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sulfuric acid
2: silver carbonate; chloroform
3: pyridine
View Scheme

7658-08-4Relevant articles and documents

Chain conformations and steady-shear viscosity properties of pectic polysaccharides from apple and tomato

Hu, Shihao,Nie, Shaoping,Wang, Junqiao,Wang, Qiang,Xu, Xiaojuan

, (2022/04/03)

In this study, apple pectin (AP) and tomato pectin (TP) were demonstrated to be a high-ester (74.8%) polysaccharide with the weight-average molecular weight (Mw) of ~ 243 kDa and a low-ester (45.9%) polysaccharide with the Mw of ~ 19 kDa, respectively. The semi-rigid chain conformations of pectic polysaccharides in NaNO3 aqueous solution were deduced according to the Smidsr?d “B values” of AP (0.025) and TP (0.029), while AP and TP exhibited higher stiffness in water due to the electric repulsion of carboxyl groups, which was visually observed by AFM images. Under steady shear, the shear-thickening behaviors of AP and TP in NaNO3 aqueous solutions were observed in the shear rate range of ?1, which were attributed to the disruption of the ordered arrangement induced by semi-rigid pectin chains into randomly entangled structure by weak shear force. AP exhibited stronger shear-thickening behavior due to the formation of more entanglements resulted from the higher Mw and longer side chains highly branched at rhamngalacturonan region. This study provides the scientific basis for the construction of the relationship of steady-shear property with chain conformation and molecular weight of pectin.

Cytotoxic triterpene and steroidal glycosides from the seeds of Digitalis purpurea and the synergistic cytotoxicity of steroidal glycosides and etoposide in SBC-3 cells

Fukaya, Haruhiko,Kuroda, Minpei,Matsuo, Yukiko,Mimaki, Yoshihiro,Takatori, Kazuhiro,Tsuchihashi, Hiroko

, (2022/03/27)

The phytochemical investigations of the seeds of Digitalis purpurea have revealed their richness in cardenolide and pregnane glycosides exhibiting potent cytotoxicity; further chemical examinations of the D. purpurea seeds have achieved the isolation of s

Four new prenylflavonol glycosides from the leaves of Cyclocarya paliurus

Ye, Zi-Jun,Sun, Hui-Hui,Chen, Zu-Hui,Wu, Jian-Ping,Li, Jing,Zhu, Hui,Huang, Lu-Lu,Chang, Xi-Wen,Ou, Sai-Yu,Wang, Wen-Xuan,He, Xiao-Ai,Zhu, Gang-Zhi,Xu, Kang-Ping

, p. 772 - 779 (2020/08/10)

Four new prenylflavonol glycosides (1–4) along with two known analogues (5–6) were isolated from the leaves of Cyclocarya paliurus for the first time. The structures of these compounds were characterized by comprehensive analysis of 1 D, 2 D NMR, HRESIMS,

A novel low-molecular-mass pumpkin polysaccharide: Structural characterization, antioxidant activity, and hypoglycemic potential

Huang, Linlin,Li, Fei,Li, Quanhong,Liang, Li,Wei, Yunlu,Yu, Guoyong

, (2020/10/02)

The novel natural low-molecular-mass polysaccharide (SLWPP-3) from pumpkin (Cucurbia moschata) was separated from the waste supernatant after macromolecular polysaccharide production and purified using a DEAE cellulose-52 column and gel-filtration chromatography. Chemical and instrumental studies revealed that SLWPP-3 with a molecular mass of 3.5 kDa was composed of rhamnose, glucose, arabinose, galactose and uronic acid with a weight ratio of 1: 1: 4: 6: 15, and primarily contained →3,6)-β-D-Galp-(1→, →4)-α-GalpA-(1→(OMe), →4)-α-GalpA-(1→, →2,4)-α-D-Rhap-(1→, →3)-β-D-Galp-(1→, →4)-α-D-Glcp, and →4)-β-D-Galp residues in the backbone. The branch chain passes were connected to the main chain through the O-4 atom of glucose and O-3 atom of arabinose. Physiologically, the ability of SLWPP-3 to inhibit carbohydrate-digesting enzymes and DPPH and ABTS radicals, as well as protect pancreatic β cells from oxidative damage by decreasing MDA levels and increasing SOD activities, was confirmed. The findings elucidated the structural types of pumpkin polysaccharides and revealed a potential adjuvant natural product with hypoglycemic effects.

α-Glucosidase inhibitory and anti-inflammatory activities of dammarane triterpenoids from the leaves of Cyclocarya paliurus

Deng, Shengping,Hao, Lili,Huang, Xishan,Huang, Yan,Li, Chenguo,Li, Jun,Liang, Cheng-qin,Liu, Wei,Su, Shanshan,Xu, Xia,Yang, Ruiyun,Zhang, Gaorong,Zhou, Dexiong

supporting information, (2021/07/22)

Diabetes mellitus is caused by chronic inflammation and affects millions of people worldwide. Cyclocarya paliurus leaves have been widely used in traditional folk tea as a remedy for diabetes, but the antidiabetic constituents remain to be further studied. The α-glucosidase inhibitory and anti-inflammatory activities were examined to evaluate their effects on diabetes mellitus, and bioassay-guided separation of C. paliurus leaves led to the identification of twenty dammarane saponins, including eleven new dammarane saponins (1–11). The structures of the isolates were elucidated by spectroscopic methods. Bioactivity assay results showed that compounds 1 and 2 strongly inhibited α-glucosidase activity, with IC50 values ranging from 257.74 μM, 282.23 μM, and strongly inhibited the release of NO, with IC50 values of 9.10 μM, 9.02 μM. Moreover, compound 2 significantly downregulated the mRNA expression of iNOS, COX-2, IL-1β, NF-κB, IL-6 and TNF-α in LPS-mediated RAW 264.7 cells and markedly suppressed the protein expression of iNOS, NF-κB/p65, and COX-2. Dammarane glucoside 2 exhibited the strongest α-glucosidase inhibitory and anti-inflammatory activities. In addition, the structure–activity relationships (SARs) of the dammarane saponins were investigated. In summary, C. paliurus leaves showed marked α-glucosidase inhibitory and anti-inflammatory activities, and dammarane saponins are responsible for regulating α-glucosidase, inflammatory mediators, and mRNA and the protein expression of proinflammatory cytokines, which could be meaningful for discovering new antidiabetic agents.

Neuroprotective and anti-inflammatory phenylethanoid glycosides from the fruits of Forsythia suspensa

Feng, Zi-Meng,Jiang, Jian-Shuang,Shao, Si-Yuan,Yang, Ya-Nan,Zhang, Fan,Zhang, Pei-Cheng

, (2021/06/15)

Neuroinflammation is emerging as a crucial reason of major neurodegenerative diseases in recent years. Increasingly evidences have supported that bioactive natural products from traditional Chinese medicines have efficiency for neuroinflammation. Forsythia suspensa, a typical medicinal herb, showed potential neuroprotective and anti-inflammatory properties in previous pharmacological studies. In our research to obtain neuroprotective and anti-inflammatory natural products, three unprecedented C6–C7′/C6–C16′ linked phenylethanoid glycoside dimers (1–3), three new phenylethanoid glycosides (4–6), and six known compounds (7–12) were isolated from the fruits of Forsythia suspensa. Their structures were determined by comprehensive spectroscopic data and comparison to the literature data. All isolated compounds were evaluated their neuroprotective and anti-inflammatory activities. Compounds 1 and 10 exhibited significant neuroprotective activities with the cell viability values of 75.24 ± 8.05% and 93.65 ± 10.17%, respectively, for the serum-deprivation and rotenone induced pheochromocytoma (PC12) cell injury. Meanwhile, compound 1 exhibited excellent anti-inflammatory activity against tumor necrosis factor (TNF)-α expression in LPS induced RAW264.7 cells with the IC50 value of 1.30 μM. This study revealed that the bioactive phenylethanoid glycosides may attenuate neuroinflammation through their neuroprotective and anti-inflammatory activities.

Two new triterpenoid glycosides from leaves of Cyclocarya paliurus

Chang, Xiwen,Chen, Huiyun,Gui, Rui,He, Xiaoai,Li, Guihua,Liu, Yiqian,Lu, Shijuan,Ou, Saiyu,Shangguan, Dangang,Sun, Huihui,Wang, Yuyan,Wu, Jianping,Xu, Kangping,Zha, Wenwen,Zhu, Hui

, (2021/05/31)

Two dammarane glycosides (1-2) were isolated from the leaves of Cyclocarya paliurus. The structures of new compounds were established by application of spectroscopic methods, including one-dimensional and two-dimensional NMR, HRESIMS, and chemical hydroly

A new sulfated triterpene glycoside from the sea cucumber Colochirus quadrangularis, and evaluation of its antifungal, antitumor and immunomodulatory activities

Han, Hua,Qi, Xin-Rui,Shen, Li,Tang, Hai-Feng,Xu, Qiang-Zhi,Yang, Wen-Sheng,Yi, Yang-Hua,Yuan, Chun-Hong

, (2021/05/21)

Our continuing search for marine bioactive secondary metabolites led to the screening of crude extracts of sea cucumbers by the model of Pyricularia oryzae. A new sulfated triterpene glycoside, coloquadranoside A (1), together with four known triterpene glycosides, philinopside A, B, E and pentactaside B (2–5) were isolated from the sea cucumber Colochirus quadrangularis, and their structures were elucidated using extensive spectroscope analysis (ESI-MS, 1D and 2D NMR) and chemical methods. Coloquadranoside A possesses a 16-acetyloxy group in the holostane-type triterpene aglycone with a 7(8)–double bond, a double bond (25,26) at its side chain, and two β-D-xylose in the carbohydrate chain. Coloquadranoside A exhibits in vitro some antifungus, considerable cytotoxicity (IC50 of 0.46–2.03 μM) against eight human tumor cell lines, in vivo antitumor, and immunomodulatory activity.

Two new iridoid glycosides from Gardeniae Fructus

Shu, Penghua,Yu, Mengzhu,Zhu, Huiqing,Luo, Yuehui,Li, Yamin,Li, Nianci,Zhang, Hui,Zhang, Jialong,Liu, Guangwei,Wei, Xialan,Yi, Wenhan

, (2021/02/26)

Two new iridoid glycosides, genipin 1,10-di-O-α-L-rhamnoside (1) and genipin 1,10-di-O-β-D-xylopyranoside (2), along with thirteen known compounds (3–15) were isolated from Gardeniae Fructus. Their structures were elucidated by physical data analyses such as NMR, UV, IR, HR-ESI-MS, as well as chemical hydrolysis. All compounds were tested for their tyrosinase inhibitory and antioxidant activities. At a concentration of 25 μM, compound 13 showed obvious mushroom tyrosinase inhibition activity with % inhibition value of 36.52 ± 1.98%, with kojic acid used as the positive control (46.09 ± 1.29%). At a concentration of 1 mM, compounds 8 and 9 exhibited considerable DPPH radical scavenging activities, with radical scavenging rates of 48.54 ± 0.47%, 58.59 ± 0.39%, respectively, with L-ascorbic acid used as the positive control (59.02 ± 0.77%).

New triterpene glycosides from the far eastern starfish solaster pacificus and their biological activity

Malyarenko, Timofey V.,Kicha, Alla A.,Kalinovsky, Anatoly I.,Dmitrenok, Pavel S.,Malyarenko, Olesya S.,Kuzmich, Alexandra S.,Stonik, Valentin A.,Ivanchina, Natalia V.

, p. 1 - 15 (2021/03/17)

Three new triterpene glycosides, pacificusosides A–C (1–3), and three previously known triterpene glycosides, cucumariosides C1 (4), C2 (5), and A10 (6), were isolated from the alcoholic extract of the Far Eastern starfish Solaster pacificus. The structures of 1–3 were elucidated by extensive NMR and ESIMS techniques and chemical transformations. Compound 1 has a novel, unique structure, containing an aldehyde group of side chains in its triterpene aglycon. This structural fragment has not previously been found in the sea cucumber triterpene glycosides or starfish steroidal glycosides. Probably, pacificusoside A (1) is a product of the metabolism of the glycoside obtained through dietary means from a sea cucumber in the starfish. Another two new triterpene glycosides (2, 3) have closely related characteristics to sea cucumber glycosides. The cytotoxicity of compounds 1–6 was tested against human embryonic kidney HEK 293 cells, colorectal carcinoma HT-29 cells, melanoma RPMI-7951 cells, and breast cancer MDA-MB-231 cells using MTS assay. Compounds 4–6 revealed the highest cytotoxic activity against the tested cell lines, while the other investigated compounds had moderate or slight cytotoxicity. The cytotoxic effects of 2–6 were reduced by cholesterol like the similar effects of the previously investigated individual triterpene glycosides. Compounds 3, 4, and 5 almost completely suppressed the colony formation of the HT-29, RPMI-7951, and MDA-MB-231 cells at a nontoxic concentration of 0.5 μM.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7658-08-4